Immunovaccine Inc's ticker is and the CUSIP is 45254B103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $206,000 | +98.1% | 110,000 | 0.0% | 0.10% | +85.2% |
Q2 2017 | $104,000 | +1055.6% | 110,000 | +1000.0% | 0.05% | +980.0% |
Q1 2017 | $9,000 | -83.6% | 10,000 | -90.9% | 0.01% | -85.3% |
Q4 2016 | $55,000 | -9.8% | 110,000 | 0.0% | 0.03% | 0.0% |
Q3 2016 | $61,000 | +7.0% | 110,000 | -8.3% | 0.03% | +6.2% |
Q2 2016 | $57,000 | +42.5% | 120,000 | 0.0% | 0.03% | +39.1% |
Q1 2016 | $40,000 | -34.4% | 120,000 | 0.0% | 0.02% | -28.1% |
Q4 2015 | $61,000 | +454.5% | 120,000 | +500.0% | 0.03% | +433.3% |
Q3 2015 | $11,000 | -87.8% | 20,000 | -83.3% | 0.01% | -86.4% |
Q2 2015 | $90,000 | +26.8% | 120,000 | 0.0% | 0.04% | +29.4% |
Q1 2015 | $71,000 | +491.7% | 120,000 | +500.0% | 0.03% | +466.7% |
Q4 2014 | $12,000 | -25.0% | 20,000 | 0.0% | 0.01% | -25.0% |
Q3 2014 | $16,000 | +23.1% | 20,000 | -1.8% | 0.01% | +14.3% |
Q2 2014 | $13,000 | -27.8% | 20,360 | 0.0% | 0.01% | -30.0% |
Q1 2014 | $18,000 | +350.0% | 20,360 | +96.5% | 0.01% | +400.0% |
Q4 2013 | $4,000 | +300.0% | 10,360 | +2777.8% | 0.00% | +100.0% |
Q3 2013 | $1,000 | 0.0% | 360 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $1,000 | – | 360 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|